MGX Volume dodolan mangsa ngarep perusahaan Metagenomi Inc.

Tandha merek Metagenomi, Inc (MGX)

Leadership in precision genome editing is driving growth, as evidenced by the planned sales levels of Metagenomi, Inc. (MGX), where the figure stands at 0.01. The business foundation is based on the ownership of unique enzymes for therapy. Sustainability is ensured through adherence to bioethics and eco-friendly production. This chart demonstrates capitalization potential driven by exclusive contracts with major pharmaceutical behemoths.

MGX - Dodolan mangsa ngarep perusahaan Metagenomi, Inc. ing rentang 21.02.2024 - 17.11.2026

Rincian metrik lan analitis perusahaan Metagenomi, Inc. (MGX)

Analisis dhasar perusahaan:MGX Metagenomi Inc.
Produk merek Metagenomi Therapeutics

For Metagenomi, Inc., whose revenues depend on partnership agreements rather than market pricing, this indicator reveals hidden revenue trends. The calculation model filters out one-time payments, converting sporadic reporting into a continuous data stream. By analyzing the company's prospective sales volume, an investor can see the real expansion dynamics of the biotech platform. The upward trend confirms the demand for DNA editing technologies; however, excessive values signal a risk of asset overvaluation.

Pesaing Metagenomi, Inc.

Volume dodolan mangsa ngarep perusahaan TEM (Tempus AI)|Dodolan mangsa ngarep perusahaan Qiagen Group|Prakiraan pendapatan perusahaan Ionis Pharma IONS|RGEN - Volume dodolan mangsa ngarep perusahaan|RNA - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan CRSP (CRISPR Therapeutics AG)|Sema4 (WGS) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan RARE (Ultragenyx)|Volume dodolan mangsa ngarep perusahaan BEAM|Prakiraan volume dodolan Sarepta Corp|Prakiraan pendapatan perusahaan Twist Bioscience, Inc. (TWST)|Volume dodolan mangsa ngarep perusahaan 10x Genomics TXG|Prakiraan pendapatan perusahaan Intellia Therapeutics NTLA|Prakiraan volume pendapatan perusahaan STOK (Stoke Therapeutics, Inc.)|BLFS - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Wave Pharma|mazetx.com (MAZE) - Prakiraan pendapatan perusahaan|SION - Dodolan mangsa ngarep perusahaan|PRME (Prime Medicine Inc) - Prakiraan volume dodolan|Taysha Gene Therapies, Inc. - Pendapatan sing dikarepake perusahaan|Prakiraan volume dodolan QURE|MGTX: Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan REGENXBIO RGNX|SLDB: Prakiraan pendapatan perusahaan|OCGN: Volume dodolan mangsa ngarep perusahaan|PACB - Prakiraan volume dodolan|BNTC (Benitec Corp) - Volume dodolan mangsa ngarep perusahaan|Prakiraan dodolan perusahaan Design Corp DSGN|Prakiraan pendapatan perusahaan Rocket Pharmaceuticals|Prakiraan volume dodolan 4D Molecular Therapeutics, Inc.|Prakiraan pendapatan perusahaan Lexeo (LXEO)|KRRO (Korro Bio Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan EDIT (Editas Medicine, Inc.)|Prakiraan volume dodolan Silence Therapeutics Corp SLN|PRQR - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan Codexis Inc CDXS|SGMO: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan NAUT|DTIL (precisionbiosciences.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GBIO (Generation Bio Co.)|Prakiraan pendapatan perusahaan Boundless Bio (BOLD)|Exicure - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan IMNN (imunon.com)|Dodolan mangsa ngarep perusahaan Phio Pharmaceuticals (PHIO)|MBIO: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Prakiraan pendapatan perusahaan|APDN - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan BLUE|Prakiraan volume dodolan immunoprecise.com|Prakiraan volume dodolan OMGA|Dodolan mangsa ngarep perusahaan Singular Genomics Corp|Regulus Therapeutics - Volume dodolan mangsa ngarep perusahaan|SYRS (Syros Pharmaceuticals) - Pendapatan sing dikarepake perusahaan|Telesis Bio Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan TCON (TRACON Pharmaceuticals Inc.)|UBX: Prakiraan volume dodolan